The ReNEW study for dry AMD is evaluating the efficacy, safety, and pharmacokinetics of daily subcutaneous injections of ...

Macular degeneration, particularly age-related macular degeneration (AMD), is a leading cause of vision loss worldwide. This condition affects the central part of the retina, known as the macula, ...

New research shows that eating this tasty snack daily can help protect against the leading cause of vision loss in older ...

Zervimesine is an investigational oral, once-daily pill being developed for the treatment of CNS diseases, including ...

Age-related macular degeneration (AMD) AMD is a common eye condition that happens as you get older. It affects the macula, ...

Luxa Biotechnology said Thursday that its stem cell therapy helped improve vision in a handful of people with a common form ...

AMD has committed to restocking its RDNA 4 graphics cards following an "unprecedented" launch for the company.

B. Riley analyst Mayank Mamtani lowered the firm’s price target on Lineage Cell Therapeutics (LCTX) to $3 from $4 and keeps a Buy rating on the ...

Your treatment options may depend on the type of macular degeneration you’ve developed. With dry AMD, any vision loss you experience cannot be reversed. However, you can slow or stop the ...

Robust, Consistent Phase 3 Data and Real-World Evidence Outcomes Support ANX005 as Potential First Targeted Therapy for GBS; Pre-BLA Meeting ...

Meanwhile, individuals who began with better baseline vision saw smaller, yet still clinically relevant, improvements that counteracted the natural decline expected in dry AMD progression.

Company will discuss its patented remote monitoring high-resolution retinal imaging system RetinalCam™ and associated ...